Report Detail

Pharma & Healthcare Global Seasonal Influenza Vaccines Market Insights, Forecast to 2025

  • RnM3522425
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Influenza vaccine typically known as flu shot and is used for protection against influenza virus. 
The global Seasonal Influenza Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Seasonal Influenza Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Seasonal Influenza Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Seasonal Influenza Vaccines in these regions.
This research report categorizes the global Seasonal Influenza Vaccines market by top players/brands, region, type and end user. This report also studies the global Seasonal Influenza Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Sinovac Biotech
Hualun Biologicals

Market size by Product
Paediatrics
Adolescence
Adults
Elderly
Market size by End User
Hospitals
Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Seasonal Influenza Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Seasonal Influenza Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Seasonal Influenza Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Seasonal Influenza Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Seasonal Influenza Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Seasonal Influenza Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Seasonal Influenza Vaccines Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Product
      • 1.4.2 Paediatrics
      • 1.4.3 Adolescence
      • 1.4.4 Adults
      • 1.4.5 Elderly
    • 1.5 Market by End User
      • 1.5.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Seasonal Influenza Vaccines Market Size
      • 2.1.1 Global Seasonal Influenza Vaccines Revenue 2014-2025
      • 2.1.2 Global Seasonal Influenza Vaccines Sales 2014-2025
    • 2.2 Seasonal Influenza Vaccines Growth Rate by Regions
      • 2.2.1 Global Seasonal Influenza Vaccines Sales by Regions
      • 2.2.2 Global Seasonal Influenza Vaccines Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Seasonal Influenza Vaccines Sales by Manufacturers
      • 3.1.1 Seasonal Influenza Vaccines Sales by Manufacturers
      • 3.1.2 Seasonal Influenza Vaccines Sales Market Share by Manufacturers
      • 3.1.3 Global Seasonal Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Seasonal Influenza Vaccines Revenue by Manufacturers
      • 3.2.1 Seasonal Influenza Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Seasonal Influenza Vaccines Revenue Share by Manufacturers (2014-2019)
    • 3.3 Seasonal Influenza Vaccines Price by Manufacturers
    • 3.4 Seasonal Influenza Vaccines Manufacturing Base Distribution, Product Types
      • 3.4.1 Seasonal Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Seasonal Influenza Vaccines Product Type
      • 3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Seasonal Influenza Vaccines Sales by Product
    • 4.2 Global Seasonal Influenza Vaccines Revenue by Product
    • 4.3 Seasonal Influenza Vaccines Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Seasonal Influenza Vaccines Breakdown Data by End User

    6 North America

    • 6.1 North America Seasonal Influenza Vaccines by Countries
      • 6.1.1 North America Seasonal Influenza Vaccines Sales by Countries
      • 6.1.2 North America Seasonal Influenza Vaccines Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Seasonal Influenza Vaccines by Product
    • 6.3 North America Seasonal Influenza Vaccines by End User

    7 Europe

    • 7.1 Europe Seasonal Influenza Vaccines by Countries
      • 7.1.1 Europe Seasonal Influenza Vaccines Sales by Countries
      • 7.1.2 Europe Seasonal Influenza Vaccines Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Seasonal Influenza Vaccines by Product
    • 7.3 Europe Seasonal Influenza Vaccines by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Seasonal Influenza Vaccines by Countries
      • 8.1.1 Asia Pacific Seasonal Influenza Vaccines Sales by Countries
      • 8.1.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Seasonal Influenza Vaccines by Product
    • 8.3 Asia Pacific Seasonal Influenza Vaccines by End User

    9 Central & South America

    • 9.1 Central & South America Seasonal Influenza Vaccines by Countries
      • 9.1.1 Central & South America Seasonal Influenza Vaccines Sales by Countries
      • 9.1.2 Central & South America Seasonal Influenza Vaccines Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Seasonal Influenza Vaccines by Product
    • 9.3 Central & South America Seasonal Influenza Vaccines by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Seasonal Influenza Vaccines by Countries
      • 10.1.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Countries
      • 10.1.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Seasonal Influenza Vaccines by Product
    • 10.3 Middle East and Africa Seasonal Influenza Vaccines by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Seasonal Influenza Vaccines Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Novartis
      • 11.2.1 Novartis Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Novartis Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Novartis Seasonal Influenza Vaccines Products Offered
      • 11.2.5 Novartis Recent Development
    • 11.3 CSL
      • 11.3.1 CSL Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 CSL Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 CSL Seasonal Influenza Vaccines Products Offered
      • 11.3.5 CSL Recent Development
    • 11.4 MedImmune
      • 11.4.1 MedImmune Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 MedImmune Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 MedImmune Seasonal Influenza Vaccines Products Offered
      • 11.4.5 MedImmune Recent Development
    • 11.5 Sanofi-Pasteur
      • 11.5.1 Sanofi-Pasteur Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Products Offered
      • 11.5.5 Sanofi-Pasteur Recent Development
    • 11.6 Solvay
      • 11.6.1 Solvay Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Solvay Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Solvay Seasonal Influenza Vaccines Products Offered
      • 11.6.5 Solvay Recent Development
    • 11.7 Sinovac Biotech
      • 11.7.1 Sinovac Biotech Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Sinovac Biotech Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Sinovac Biotech Seasonal Influenza Vaccines Products Offered
      • 11.7.5 Sinovac Biotech Recent Development
    • 11.8 Hualun Biologicals
      • 11.8.1 Hualun Biologicals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Hualun Biologicals Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Hualun Biologicals Seasonal Influenza Vaccines Products Offered
      • 11.8.5 Hualun Biologicals Recent Development

    12 Future Forecast

    • 12.1 Seasonal Influenza Vaccines Market Forecast by Regions
      • 12.1.1 Global Seasonal Influenza Vaccines Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Seasonal Influenza Vaccines Revenue Forecast by Regions 2019-2025
    • 12.2 Seasonal Influenza Vaccines Market Forecast by Product
      • 12.2.1 Global Seasonal Influenza Vaccines Sales Forecast by Product 2019-2025
      • 12.2.2 Global Seasonal Influenza Vaccines Revenue Forecast by Product 2019-2025
    • 12.3 Seasonal Influenza Vaccines Market Forecast by End User
    • 12.4 North America Seasonal Influenza Vaccines Forecast
    • 12.5 Europe Seasonal Influenza Vaccines Forecast
    • 12.6 Asia Pacific Seasonal Influenza Vaccines Forecast
    • 12.7 Central & South America Seasonal Influenza Vaccines Forecast
    • 12.8 Middle East and Africa Seasonal Influenza Vaccines Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Seasonal Influenza Vaccines Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Seasonal Influenza Vaccines. Industry analysis & Market Report on Seasonal Influenza Vaccines is a syndicated market report, published as Global Seasonal Influenza Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Seasonal Influenza Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report